{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"Number of surviving participants without disease progression or death for any reason at one year post treatment. Kaplan-Meier method was used.","groups":[{"description":"Akt inhibitor MK2206 200 mg orally once a week, repeats every 28 days for up to 12 courses.","id":"OG000","title":"Akt Inhibitor MK2206"}],"populationDescription":"PI is not available, therefore, no data is available for reporting in this section due to the overall survival was not an outcome to be measured initially. All efforts were made to retrieve data.","reportingStatus":"POSTED","timeFrame":"From the start of treatment to death or 30 days after removal from the study whichever occurs first","title":"Overall Survival","type":"SECONDARY"}